The effects of captopril and losartan on erythrocyte membrane Na⁺/K⁺- ATPase activity in experimental diabetes mellitus

References

• Parving HH. Effects of ACE inhibitors on renal function in incipient and overt diabetic nephropathy. J Diabet Comp 1996; 10(3)133–135
   PubMed Web of Science ®Google Scholar
• Vivian EM, Goebig LM. Slowing the progression of renal disease in diabetic patients. Ann Pharmacother 2001; 35: 452–463
   PubMed Web of Science ®Google Scholar
• Ustundag B, Cay M, Naziroglu N, Dilsiz N, Crabbe MJC, Ilhan N. The study of renin-aldesteron in experimental diabetes mellitus cell. Biochem Funct 1999; 17: 193–198
   PubMed Web of Science ®Google Scholar
• Szkudelski T, Szkudelska K. Streptozotocin induces lypolysis in rat adipocytes in vitro. Physiol Res 2002; 51: 255–259
   PubMed Web of Science ®Google Scholar
• Vague P, Coste TC, Jannot MF, Raccah D, Tsimaratos M. C-peptide, Na⁺/K⁺ ATPase, and diabetes. Exp Diab Res 2004; 5: 37–50
   Google Scholar
• Koc B, Erten V, Yilmaz MI, Sonmez A, Kocar IH. The relationship between red blood cell Na+/K+ ATPase activities and diabetic complications in patients with type 2 diabetes mellitus. Endocrine 2003; 21(3)273–278
   PubMed Web of Science ®Google Scholar
• Murali B, Goyal RK. Effect of chronic treatment with losartan on streptozotocin induced diabetic nephropathy. Clin Exp Hypertens 2001; 23(7)513–520
   PubMed Web of Science ®Google Scholar
• Andersen S, Tarnow L, Rossing P, Hansen BV, Parving HH. Renoprotective effects of angiotensin II receptor blockade in type 1 diabetic patients with diabetic nephropathy kidney. Int 2000; 57(2)601–606
   Google Scholar
• Raccah D, Fabreguettes C, Azulay JP, Vague P. Erythrocyte Na/K ATPase activity metabolic control and neuropathy in IDDM patients. Diab Care 1996; 19(6)564–568
   PubMed Web of Science ®Google Scholar
• Santoro R, De la Riva IJ. Effect of captopril on Na/ K ATPase and Mg ATPase activity. Pharm Res Commun 1985; 17(4)323–330
   PubMedGoogle Scholar
• Luheshi GN, Zar MA. The effecets of streptozotocin-induced diabetes on cholinergic motor transmission in the rat urinary bladder. Br J Pharmacol 1991; 193: 265–275
   Google Scholar
• Stevens EJ, Willars GB, Lidbury P, House F, Tomlinson DR. Vasoreactivity and prostacyclin release in streptozotocin-diabetic rats: Efect of insulin or aldose reductase inhibition. Br J Pharmacol 1993; 234: 281–285
   Google Scholar
• Kiff RJ, Gardnier SM, Compton AM, et al. The effects of endothelin-1 and NG-nitro-L arginine methyl ester on regional haemodynamics in conscious rats with streptozotocin-induced diabetes mellitus. Br J Pharmacol 1991; 103: 1321–1326
   PubMed Web of Science ®Google Scholar
• Kiff RJ, Gardnier SM, Compton AM, Bennett T. Selective impairment of hindquaters responses to bradykinin in conscious wistar rats with streptozotocin-induced diabetes mellitus. Br J Pharmacol 1991; 103: 1357–1362
   PubMed Web of Science ®Google Scholar
• Yavuz DG, Ersöz O, Kucukkaya B, Yasemin B, Ahiskali R, Ekicioglu G, Emerk K, Akalin S. The effect of losartan and captopril on glomerular basement membrane anionic charge in a diabetic rat model. J Hypertens 1999; 17: 1217–1223
   PubMed Web of Science ®Google Scholar
• Sun Y, Frederick AO, Mendelsohn O. Angiotensin converting enzyme inhibition in heart, kidney, and serum studied ex vivo after administration of zefenopril, captopril, and lisinopril. J Cardiovasc Pharm 1991; 18(4)478–486
   PubMed Web of Science ®Google Scholar
• Kanbak G, Akyuz F, Inal M. Preventive effect of betaine on ethanol-induced membrane ATPases. Arch Toxicol 2001; 75: 59–61
   PubMed Web of Science ®Google Scholar
• Mateucci C, Cocci FF, Pellegrini L, Gregori G, Giampietro O. Measurement of ATPases in red cells: Setting up and validation of a highly reproduciple method. Enz Protein 1995; 48: 115–119
   Google Scholar
• Holmquist B, Bunning P, Riordan JF. A continuous spectrophotometric assay for angiotensin converting enzyme. Anal Biochem 1987; 95: 540–545
   Web of Science ®Google Scholar
• El-Batran SA, El-Shenawy SM, Nofal SM, Abdel-salam OM, Arbid MS. Losartan in normal and diabetic rats. Pharm Res 2004; 50: 131–136
   Web of Science ®Google Scholar
• Shionori H, Lino S, Inoue S. Glucose metabolism during captopril mono- and combination therapy in dibetic hypertensive patients: A multiclinic trial. Clin Exp Theory Pract 1987b; A9: 671–674
   Google Scholar
• Liu G, Guan GJ, Qi TG, Fu YQ, Sun Y, Wen RZ. Protective effects of Salvia miltiorrhiza on rats with steptozotocin diaebetes and its mechanism. Zhong Xi Yi Jie He Xue Bao 2005; 3(6)459–462
   PubMedGoogle Scholar
• Katoh M, Ohmachi Y, Kurosawa Y, Yoneda H, Tanaka N, Narita H. Effects of imidapril and captopril on streptozotocin-induced diabetic nephropathy. Eur J Pharmacol 2000; 398: 381–387
   PubMed Web of Science ®Google Scholar
• Zandbergen AA, Baggen MG, Lamberts SW, Bootsma AH, Zeeuw D, Ouwendijk RJ. Effect of losartan on microalbuminurea in normotensive petients type 2 diabetes mellitus. A randomized clinical trial. Ann Intern Med 2003; 139(2)90–96
   PubMed Web of Science ®Google Scholar
• Gilbert RE, Cox A, Wu LL, Allen TJ, Hulthen UL, Jerums G, Coopr ME. Expression of transforming growth factor-beta 1 and type IV collagen in the renal tubulointerstitium in experimental diabetes: Effects of ACE inhibition. Diabetes 1998; 47: 414–422
   PubMed Web of Science ®Google Scholar
• Hostetter TH. Mechanism of diabetic nephropathy. Am J Kidney Dis 1994; 23(2)188–192
   PubMed Web of Science ®Google Scholar
• Renke M, Tylicki L, Rutkowski P, Lysiak-Sydlowska W, Rutkowski B. Low-dose angiotensin II receptor antagonists and angiotensin II-converting enzyme inhibitors alone or in combination for treatment of primary glomerulonephritis. Scand J Urol Nephrol 2004; 38(5)427–433
   PubMed Web of Science ®Google Scholar
• Imanıshi M, Yoshioka K, Okumura M, Konishi Y, Tanaka S, Fujii S, Kimura G. Mechanism of decreased albuminuria caused by angiotensin converting enzyme inhibitor in early diabetic nephropathy. Kidney Int 1997; 52(63)198–200
   Google Scholar
• Edmund J, Lawrence MD, Hunsicker G. The effect of angiotensin-converting enzyme inhibition on diabetic nephropathy. New Engl J Med 1993; 329(20)1456–1462
   PubMed Web of Science ®Google Scholar
• Tylicki L, Biedunkiewicz B, Chamienia A, Wojnarowski K, Zdrojewski Z, Rutkowski B. Randomized placebo-controlled study of the effects of losartan and carvedilol on albuminuria in renal transplant recipients. Transplantation 2006; 81: 52–56
   PubMed Web of Science ®Google Scholar
• Kennefick TM, Anderson S. Role of angiotensin II in diabetic nephropathy. Sem Nephrology 1997; 17(5)441–447
   PubMed Web of Science ®Google Scholar
• Leehey DJ, Singh AK, Alavi N. Role of angiotensin II in diabetic nephropathy Kidney. Int 2000; 58(77)93–98
   Google Scholar
• Erman A, Chen-Gal B, David I. Insulin treatment reduces the increased serum and lung angiotensin-converting enzyme activity in streptozotocin-induced diabetic rats. Scand J Clin Invest 1998; 58: 81–88
   PubMed Web of Science ®Google Scholar
• Mizuiri S, Kobayashi M, Nakanishi T. Renal angiotensin-converting enzyme localization in diabetic rats and the effect of low protein diet. Nephron 1997; 76: 186–191
   PubMed Web of Science ®Google Scholar
• Prakasam A, Sethupathy S, Pugalendi KV. Modulating role of Saptarangi esculenta on membrane bound ATPase in streptozotocin diabetic rats. Pharmazie 2005; 60(11)874–877
   PubMed Web of Science ®Google Scholar
• Bagrov YY, Manusova NB, Egorova JA, Fedorova OV, Bagrov AY. Endogenous digitalis-like ligands and Na+/K+ ATPase inhibition in experimental diabetes mellitus. Front Biosci 2005; 10: 2257–2262
   PubMed Web of Science ®Google Scholar
• Jannot MF, Raccah D, De La Tour DD, Coste T, Gouvernet J, Vague P. Relationship between neuropathy, hypertension and red blood cell Na+/K+ ATPase in patients with insulin-dependent diabetes mellitus. Diab Metab 1999; 25(1)35–42
   PubMed Web of Science ®Google Scholar
• Accetto R, Rinaldi G, Weder BA. Captopril inhibits quabain-sensitive on Na+/K+ ATPase. Clin Physiol Biochem 1989; 7: 101–108
   PubMedGoogle Scholar